Latigo Biotherapeutics Secures $150 Million in Series B Funding to Propel Development of Non-Opioid Pain Treatments Read more
Zealand Pharma and Roche Partner to Co-Develop Petrelintide for Overweight and Obesity Treatment Read more
Emergent BioSolutions and Rocketvax Announce Investment Agreement to Advance Next-Generation Product Candidates Read more